Chromosomes are masters of organization. These long strings of DNA fold down into an ensemble of compact structures that keep needed parts of the genome accessible while tucking away those that aren't ...

You'll get access to an ad-free website with a faster photo browser, the chance to claim free tickets to a host of events (including everything from Summerfest to the Milwaukee Film Festival), access ...

Robin Rowe talks about coding, programming education, and China in the age of AI feature TrapC, a memory-safe version of the ...

RapidFuzz is a fast string matching library for Python and C++, which is using the string similarity calculations from FuzzyWuzzy. However, there are two aspects that set RapidFuzz apart from ...

Adam Wharton is the subject of our feature interview for the first programme of 2026. When asked why he is often selected as 'data analyst' in our staff selection feature, Wharton said: "They probably ...

It may be embroiled in a number of controversies – but the BBC battered rival ITV in the Christmas Day ratings war. The Beeb occupied nine of the top ten spots for the most-watched festive television ...

The Audubon Zoo is collecting lights to raise money for lion habitats. Multiple parishes are saving trees to help restore wetlands. I figured out why Congress has been so willing to do nothing | ...

CNBC ranks the 75 most valuable college athletic programs. The programs are worth a combined $51.22 billion, 13% more than the top 75 in last year's rankings. Earlier this month the University of Utah ...

Cambridge leaders said they are preparing to make city-wide budget cuts to brace for what they believe will be a multi-year economic slowdown in a “sobering” round table meeting with the City Council ...

DOT's recent "emergency" rulemaking that seeks to purge nearly 200,000 non-domiciled CDL holders from trucking, called out a litany of licensing lapses and six states specifically for not following ...

After axing a wide swath of federal research projects and grants, a recent slew of awards offers a glimpse into the kinds of science the second Trump administration wants to back: in vivo cell ...